Stoxx Europe 50
5.332,74
PKT
+8,51
PKT
+0,16
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.11.22 | Novo Nordisk Neutral | Credit Suisse Group | |
| 03.11.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.11.22 | GSK Equal Weight | Barclays Capital | |
| 03.11.22 | AXA Overweight | Barclays Capital | |
| 03.11.22 | BP Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.11.22 | AXA Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.11.22 | Rio Tinto Hold | Deutsche Bank AG | |
| 03.11.22 | GSK Hold | Deutsche Bank AG | |
| 03.11.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.11.22 | ING Group Sector Perform | RBC Capital Markets | |
| 03.11.22 | Schneider Electric Underperform | Bernstein Research | |
| 03.11.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 03.11.22 | LOréal Underperform | Jefferies & Company Inc. | |
| 02.11.22 | AXA Buy | Jefferies & Company Inc. | |
| 02.11.22 | Enel Buy | Jefferies & Company Inc. | |
| 02.11.22 | GSK Neutral | UBS AG | |
| 02.11.22 | Santander Neutral | JP Morgan Chase & Co. | |
| 02.11.22 | BP Overweight | Barclays Capital | |
| 02.11.22 | Hermès (Hermes International) Overweight | Barclays Capital | |
| 02.11.22 | BP Buy | UBS AG | |
| 02.11.22 | Novo Nordisk Sell | UBS AG | |
| 02.11.22 | Deutsche Telekom Buy | UBS AG | |
| 02.11.22 | BNP Paribas Equal Weight | Barclays Capital | |
| 02.11.22 | BP Buy | Deutsche Bank AG | |
| 02.11.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.11.22 | Unilever Buy | Jefferies & Company Inc. | |
| 02.11.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.11.22 | Nestlé Underperform | Jefferies & Company Inc. | |
| 02.11.22 | BBVA Neutral | Goldman Sachs Group Inc. | |
| 02.11.22 | BAT Neutral | Goldman Sachs Group Inc. | |
| 01.11.22 | Prosus Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.11.22 | Santander Sector Perform | RBC Capital Markets | |
| 01.11.22 | AstraZeneca Overweight | Barclays Capital | |
| 01.11.22 | Unilever Sell | UBS AG | |
| 01.11.22 | BP Buy | UBS AG | |
| 01.11.22 | BP Outperform | RBC Capital Markets | |
| 01.11.22 | BP Neutral | JP Morgan Chase & Co. | |
| 01.11.22 | ASML NV Buy | UBS AG | |
| 01.11.22 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.11.22 | Roche Hold | Deutsche Bank AG |
